WO2010044095A3 - Proline rich polypeptide from colostrum - Google Patents

Proline rich polypeptide from colostrum Download PDF

Info

Publication number
WO2010044095A3
WO2010044095A3 PCT/IN2009/000485 IN2009000485W WO2010044095A3 WO 2010044095 A3 WO2010044095 A3 WO 2010044095A3 IN 2009000485 W IN2009000485 W IN 2009000485W WO 2010044095 A3 WO2010044095 A3 WO 2010044095A3
Authority
WO
WIPO (PCT)
Prior art keywords
colostrum
rich polypeptide
mammalian colostrum
psi
proline
Prior art date
Application number
PCT/IN2009/000485
Other languages
French (fr)
Other versions
WO2010044095A2 (en
Inventor
Pawan Saharan
Original Assignee
Pawan Saharan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pawan Saharan filed Critical Pawan Saharan
Publication of WO2010044095A2 publication Critical patent/WO2010044095A2/en
Publication of WO2010044095A3 publication Critical patent/WO2010044095A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Present invention relates to an immunologically active nonapeptide fragments of a proline-rich polypeptide isolated from mammalian colostrum for treatment of viral and non-viral diseases or diseased conditions, a method and a system for processing mammalian colostrum for isolating target peptides and proteins, a pharmaceutical formulation containing such peptides and its use for the treatment of viral diseases or diseased conditions. The product comprises proline-rich polypeptide of immuno regulatory properties. The method of processing include, steps of passing a body fluids, such as, mammalian colostrum through at least one ion exchange column such as an anionic resin and/or a cationic resin. The ion exchange column can be selected to retained large particles at a first pH level selected to remove such large particles at a maximum fluid pressure of 30 pounds per square inch (psi), preferably less than 10 psi.
PCT/IN2009/000485 2008-09-04 2009-09-03 Novel immunologically active peptide fragments of a proline- rich polypeptide isolated from mammalian colostrums for treatment of viral and non-viral diseases or diseased conditions WO2010044095A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1874/MUM/2008 2008-09-04
IN1874MU2008 2008-09-04

Publications (2)

Publication Number Publication Date
WO2010044095A2 WO2010044095A2 (en) 2010-04-22
WO2010044095A3 true WO2010044095A3 (en) 2010-06-10

Family

ID=42106988

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000485 WO2010044095A2 (en) 2008-09-04 2009-09-03 Novel immunologically active peptide fragments of a proline- rich polypeptide isolated from mammalian colostrums for treatment of viral and non-viral diseases or diseased conditions

Country Status (1)

Country Link
WO (1) WO2010044095A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164281A (en) 2010-11-23 2017-11-30 Pantheryx Inc Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
PL235821B1 (en) * 2014-11-04 2020-11-02 Geo Poland Spolka Z Ograniczona Odpowiedzialnoscia High-proline peptide complex for applications in the prophylaxis and treatment support of disorders and morbidities related to changes in the neurotrophic factor of brain origin, and for modulating it

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007079052A2 (en) * 2005-12-29 2007-07-12 Andrew Maurice Keech Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions
US20070212367A1 (en) * 2006-03-13 2007-09-13 Keech Andrew M Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007079052A2 (en) * 2005-12-29 2007-07-12 Andrew Maurice Keech Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions
US20070212367A1 (en) * 2006-03-13 2007-09-13 Keech Andrew M Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions

Also Published As

Publication number Publication date
WO2010044095A2 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
WO2019224025A3 (en) Antagonizing cd73 antibody
AU2010288559A8 (en) New endolysin OBPgpLYS
WO2008142164A3 (en) Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
WO2005003296A3 (en) Albumin fusion proteins
WO2008033413A3 (en) Albumin fusion proteins
WO2007021494A3 (en) Albumin fusion proteins
WO2008133663A3 (en) Codon modified immunogenic compositions and methods of use
WO2007104529A3 (en) Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
MX2022010175A (en) Flt3 binding proteins and methods of use.
GB201018518D0 (en) Novel endolysin
EP2336174A3 (en) Human monoclonal antibodies against Hendra and Nipah viruses
WO2009115531A3 (en) Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions
WO2011036445A3 (en) Polypeptides and uses thereof
WO2008124646A3 (en) Use of amyloid proteins as vaccine scaffolds
WO2011036442A3 (en) Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders
WO2019197567A3 (en) Antigenic peptides for prevention and treatment of cancer
WO2003030821A3 (en) Albumin fusion proteins
CN107849551A (en) New trypsase is the same as work(iso series and its purposes
WO2012018907A3 (en) Polypeptides for treating and/or limiting influenza infection
WO2008040190A8 (en) Small peptides for anti-angiogenesis and use thereof
WO2018224573A8 (en) Recombinant measles virus expressing zika virus proteins and their applications
WO2021181233A3 (en) Cd80-fc fusion protein and uses thereof
EP2236608A3 (en) Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
WO2020163743A8 (en) Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
WO2008060776A3 (en) Atap peptides, nucleic acids encoding the same and associated methods of use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09820345

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09820345

Country of ref document: EP

Kind code of ref document: A2